StarTric
StarTric develops a minimally invasive device addressing Tricuspid Regurgitation (TR).
Milan, Italywww.startric.it ↗
Total raised
€0
€0
Funding rounds
1
Investors
3
distinct backers
Active since
2024-07
latest 2024-07
Funding by year
EUR raised per yearSignals
Medium confidenceRaise-next likelihood32
base rate 44% for Seed
- ▼ Overdue vs cohort gap
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-07-09 | Seed | — | Business Angels,Growth Engine ,NLC Health Impact Fund | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Bending Spoons€1.7BItaly · Software
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Oura Health€779MFinland · Healthtech